Clinical Trial Update: Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ranolazine for diabetic peripheral neuropathic pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Horizons International Peripheral Group | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 4 | Status: TERMINATED